OBJECTIVE： To establish the Evaluation Criteria on Rational Use of Human Serum Albumin （HSA） in our hospital， and to provide refereuce for rational use of HSA. METHODS： Referring to drug utilization evaluation （DUE） criteria of WHO and developed countries， based on the guideline of HSA use， Human Serum Albumin， Non-protein Colloid and Crystalloid Solution Guidelines of USA University Hospital Consortium， Blood Products Prescription Evaluation Guideline of Beijing area， etc.， Evaluation Criteria on Rational Use of HAS was established through experts discussion， and the use of HAS in 420 patients of our hospital were evaluated. RESULTS： The Evaluation Criteria on Rational Use of HSA mainly included indication， contraindication， usage and dosage， drug combination， incompatibility， etc. 414 patients （98.57％） detected serum albumin concentration before treatment； 167 patients （39.76％） were in line with the indication； 56 patients （13.33％） had contraindication in using HSA； 352 patients （83.81％） met the criteria in usage and dosage， duration of treatment； there were 17 cases （4.05％） of unreasonable drug combination and 3 cases （0.71％） of incompatibility.  CONCLUSIONS： The established criteria has strong practicability， and some problems and insufficiencies can be found in the clinical practice， is conducive to promote rational drug use in the clinic.